专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20080103123A1 New compounds 审中-公开
标题翻译：新化合物
公开(公告)号：US20080103123A1
公开(公告)日：2008-05-01
申请号：US11897436
申请日：2007-08-29
申请人： Peter Brandt , Rikard Emond , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall , Michael Weber
发明人： Peter Brandt , Rikard Emond , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall , Michael Weber
IPC分类号： A61K31/4545 , A61K31/397 , A61K31/5355 , A61K31/5377 , A61P3/00 , C07D211/22 , C07D413/14
CPC分类号： A61K31/4545 , A61K31/496 , A61K45/06 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/14 , A61K2300/00
摘要： The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, hydrates, geometrical isomers, racemates, tautomers, optical isomers and N-oxides thereof, wherein one of W1 and W2 is N and the other is CR12. The invention also relates to pharmaceutical compositions comprising these compounds, and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein-coupled receptor GPR119, such as diabetes and obesity.
摘要翻译：本发明涉及式（Ia）化合物及其药学上可接受的盐，水合物，几何异构体，外消旋体，互变异构体，旋光异构体和N-氧化物，其中W 1和 2 是N，另一个是CR 12。本发明还涉及包含这些化合物的药物组合物，以及这些化合物用于预防和治疗与G蛋白偶联受体GPR119的疾病如糖尿病和肥胖有关的医学病症的用途。

2. 发明申请

US20080103141A1 New compounds 审中-公开
标题翻译：新化合物
公开(公告)号：US20080103141A1
公开(公告)日：2008-05-01
申请号：US11897400
申请日：2007-08-29
申请人： Peter Brandt , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall , Michael Weber
发明人： Peter Brandt , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall , Michael Weber
IPC分类号： A61K31/506 , A61K31/5377 , A61P3/00 , C07D239/34 , C07D413/14
CPC分类号： A61K31/4545 , A61K31/496 , A61K45/06 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/14 , A61K2300/00
摘要： The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, hydrates, geometrical isomers, racemates, tautomers, optical isomers and N-oxides thereof, wherein W1 and W3 are N and W2 and W4 are CR12, or W1 and W3 are CR12 and W2 and W4 are N. The invention also relates to pharmaceutical compositions comprising these compounds, and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein-coupled receptor GPR119, such as diabetes and obesity.
摘要翻译：本发明涉及式（Ia）化合物及其药学上可接受的盐，水合物，几何异构体，外消旋体，互变异构体，旋光异构体和N-氧化物，其中W 1和W 3， / SUP>是N，W 2和W 4是CR 12，或W 1和W SUP > 3是CR 12，W 2和W 4是N.本发明还涉及包含这些化合物的药物组合物，以及这些化合物用于预防和治疗与G蛋白偶联受体GPR119的病症有关的医学病症如糖尿病和肥胖症的用途。

3. 发明申请

US20080058339A1 New compounds 审中-公开
标题翻译：新化合物
公开(公告)号：US20080058339A1
公开(公告)日：2008-03-06
申请号：US11897392
申请日：2007-08-29
申请人： Peter Brandt , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall
发明人： Peter Brandt , Gary Johansson , Lars Johansson , Tobias Koolmeister , Bjorn Nilsson , Teresa Sandvall
IPC分类号： A61K31/501 , A61P25/00 , A61P3/00 , A61P9/00 , C07D401/12
CPC分类号： A61K31/4545 , A61K31/496 , A61K45/06 , C07D401/12 , C07D401/14 , C07D405/14 , C07D413/14 , A61K2300/00
摘要： The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, hydrates, geometrical isomers, racemates, tautomers, optical isomers and N-oxides thereof. The invention also relates to pharmaceutical compositions comprising these compounds, and to the use of these compounds for the prophylaxis and treatment of medical conditions relating to disorders of the G-protein-coupled receptor GPR119, such as diabetes and obesity.
摘要翻译：本发明涉及式（I）的化合物及其药学上可接受的盐，水合物，几何异构体，外消旋体，互变异构体，旋光异构体及其N-氧化物。本发明还涉及包含这些化合物的药物组合物，以及这些化合物用于预防和治疗与G蛋白偶联受体GPR119的疾病如糖尿病和肥胖有关的医学病症的用途。

4. 发明申请

US20080039450A1 Compounds 审中-公开
标题翻译：化合物
公开(公告)号：US20080039450A1
公开(公告)日：2008-02-14
申请号：US11821565
申请日：2007-06-21
申请人： Annika Jensen , Rune Ringom , Carmen Medina , John Vock , Marie Wiik , Tobias Koolmeister , Johan Angbrant , Martin Henriksson , Teresa Sandvall , Lori Sutin , Lars Johannson , Bjorn Nilsson
发明人： Annika Jensen , Rune Ringom , Carmen Medina , John Vock , Marie Wiik , Tobias Koolmeister , Johan Angbrant , Martin Henriksson , Teresa Sandvall , Lori Sutin , Lars Johannson , Bjorn Nilsson
IPC分类号： A61K31/5377 , A61K31/4439 , A61K31/496 , A61P25/00 , A61P3/00 , A61P9/00 , C07D401/04 , C07D403/10 , C07D405/04 , C07D417/12 , C07D413/14 , C07D413/10 , C07D405/12 , C07D403/12 , C07D401/14 , C07D241/20 , A61P35/00 , A61P29/00 , A61K31/541 , A61K31/4965
CPC分类号： C07D401/12 , C07D401/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D471/04
摘要： The present invention relates to compounds of the general formula I wherein X, Y, Z, A, Ar, R1, R2, R3, and R4 are as defined herein, which compounds are inhibitors of MNK2 and MNK1. The invention also relates to the use of the compounds in therapy, pharmaceutical compositions comprising the compounds, and the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of disorders related to undesired activity of MNK1 and/or MNK2 kinases.
摘要翻译：本发明涉及通式I的化合物，其中X，Y，Z，A，Ar，R 1，R 2，R 3， >和R 4如本文所定义，这些化合物是MNK2和MNK1的抑制剂。本发明还涉及化合物在治疗中的用途，包含该化合物的药物组合物，以及该化合物在制备用于预防和治疗与MNK1和/或MNK2激酶的不期望活性相关的疾病的药物中的用途。

5. 发明申请

US20080032968A1 New compounds 有权
标题翻译：新化合物
公开(公告)号：US20080032968A1
公开(公告)日：2008-02-07
申请号：US11824939
申请日：2007-07-03
申请人： Joean Angbrant , Rune Ringom , Kristin Hammer , Erie Ringberg , Bengt Lindqvist , Gary Johansson , Peter Brandt , Katarina Beterlein , Bjorn Nilsson
发明人： Joean Angbrant , Rune Ringom , Kristin Hammer , Erie Ringberg , Bengt Lindqvist , Gary Johansson , Peter Brandt , Katarina Beterlein , Bjorn Nilsson
IPC分类号： A61K31/55 , A61K31/405 , A61K31/445 , A61P3/00 , C07D243/08 , C07D403/00 , C07D401/00 , C07D209/04 , A61K31/497 , A61K31/535
CPC分类号： C07D401/06 , C07D209/08 , C07D401/12 , C07D403/06 , C07D409/12 , C07D417/12 , C07D417/14 , C07D513/04
摘要： The present invention relates to novel compounds of formula (I): wherein m, n, R0, R1, R2, R3 and R4 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
摘要翻译：本发明涉及新的式（I）化合物：其中m，n，R 0，R 1，R 2，R 2， SUP 3+和R 4如本文所述，涉及包含该化合物的药物组合物，其制备方法以及该化合物在制备药物中的用途针对5-HT 6受体相关病症。

6. 发明申请

US20060287291A1 Compounds 失效
标题翻译：化合物
公开(公告)号：US20060287291A1
公开(公告)日：2006-12-21
申请号：US11018019
申请日：2004-12-20
申请人： Gary Johansson , Peter Brandt , Bjorn Nilsson
发明人： Gary Johansson , Peter Brandt , Bjorn Nilsson
IPC分类号： A61K31/551 , A61K31/5377 , A61K31/4745 , A61K31/498 , A61K31/497 , A61K31/496 , A61K31/506 , A61K31/452 , A61K31/4433 , A61K31/4178 , A61K31/397 , A61K31/343 , C07D405/02 , C07D413/02
CPC分类号： C07D307/79 , C07D307/82 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/06 , C07D405/12 , C07D409/12 , C07D409/14 , C07D453/02 , C07D487/08 , C07D495/04
摘要： The present invention relates to compounds of formula (I): wherein P, R3, W1, and W2 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
摘要翻译：本发明涉及式（I）化合物：其中P，R 3，W 1和W 2 2如本文所述，涉及包含该化合物的药物组合物，其制备方法，以及该化合物用于制备抗5-HT 6受体相关病症的药物的用途。

7. 发明申请

US20060148818A1 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders 审中-公开
标题翻译：新颖的tetraydrospiro（哌啶-2,7'-吡咯并[3,2-b]吡啶衍生物和可用于治疗5-ht6受体相关疾病的新颖的脱氨基衍生物
公开(公告)号：US20060148818A1
公开(公告)日：2006-07-06
申请号：US10536603
申请日：2004-10-20
申请人： Gary Johansson , Peter Brandt , Graeme Dykes , Bjorn Nilsson
发明人： Gary Johansson , Peter Brandt , Graeme Dykes , Bjorn Nilsson
IPC分类号： A61K31/496 , A61K31/4747 , A61K31/4439 , A61K31/405 , C07D471/10 , C07D403/02
CPC分类号： C04B35/632 , C07D209/08 , C07D401/12 , C07D403/04
摘要： The present invention relates to compounds of formula (I): Formula (I) wherein U, P, W1, W2, W3, v, Y, Z, Rm, and Rm′ are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
摘要翻译：本发明涉及式（I）化合物：式（I）其中U，P，W 1，W 2，W 3，，v，Y，Z，R m和R m'如本文所述，涉及包含该化合物的药物组合物，其制备方法以及所述化合物用于制备针对5-HT 6受体相关病症的药物的用途。

8. 发明申请

US20050256106A1 Novel compounds, their use and preparation 失效
标题翻译：新型化合物，其用途及制备方法
公开(公告)号：US20050256106A1
公开(公告)日：2005-11-17
申请号：US11057033
申请日：2005-02-11
申请人： Patrizia Caldirola , Bjorn Nilsson , Gary Johansson
发明人： Patrizia Caldirola , Bjorn Nilsson , Gary Johansson
IPC分类号： A61P25/00 , C07D209/08 , C07D401/12 , C07D403/12 , C07D409/12 , C07D453/02 , C07D487/04 , C07D487/08 , A61K31/551 , A61K31/4745 , A61K31/496 , A61K31/498 , C07D453/04 , C07D43/02
CPC分类号： C07D401/12 , C07D209/08 , C07D403/12 , C07D409/12 , C07D453/02 , C07D487/04 , C07D487/08
摘要： The invention-provides 2, 3-, 4- or 5-substituted-N1-(arylsulfonyl)indole and (heteroaryl)indole compounds of the general formula (I): in which Ar, R2, R3, R4 and R5 are as defined in the specification. The compounds bind to the 5-HT6 receptor and are useful for the treatment and prophylaxis of disorders mediated by the 5-HT6 receptor, such as obesity and CNS disorders.
摘要翻译：本发明提供通式（I）的2,3-，4-或5-取代的N1-（芳基磺酰基）吲哚和（杂芳基）吲哚化合物：其中Ar，R 2， R 3，R 4和R 5如说明书中所定义。该化合物与5-HT 6受体结合，可用于治疗和预防由5-HT 6受体介导的疾病，例如肥胖症和CNS障碍。

9. 发明授权

US08174463B2 System and method for updating electronic label displays 有权
标题翻译：更新电子标签显示的系统和方法
公开(公告)号：US08174463B2
公开(公告)日：2012-05-08
申请号：US12466459
申请日：2009-05-15
申请人： Par Rosander , Lars Andersson , Bjorn Nilsson
发明人： Par Rosander , Lars Andersson , Bjorn Nilsson
IPC分类号： G09G5/00
CPC分类号： G06F3/1423 , G06F3/147 , G06Q20/201 , G09G2380/04
摘要： An electronic label wirelessly connected to a product information updating system. The electronic label includes a wireless communication interface to receive information from a server to be displayed on a display, a means for processing connected to the communication interface, a means for updating the display connected to the means for processing, and at least one dot matrix display to display a dot matrix image, where the dot matrix display is connected to the means for updating the display. The communication interface receives the information to be displayed from the product information updating system. At least a part of the dot matrix display displays a first barcode that can be scanned by a barcode scanner, where the first barcode identifies the electronic label or a product linked to the electronic label.
摘要翻译：无线连接到产品信息更新系统的电子标签。电子标签包括：无线通信接口，用于从显示器上显示的服务器接收信息，连接到通信接口的处理装置，用于更新连接到处理装置的显示装置，以及至少一个点矩阵显示以显示点阵图像，其中点阵显示器连接到用于更新显示器的装置。通信接口从产品信息更新系统接收要显示的信息。点阵显示器的至少一部分显示可由条形码扫描仪扫描的第一条形码，其中第一条形码标识电子标签或与电子标签相关的产品。

10. 发明申请

US20090225000A1 SYSTEM AND METHOD FOR UPDATING ELECTRONIC LABEL DISPLAYS 有权
标题翻译：用于更新电子标签显示的系统和方法
公开(公告)号：US20090225000A1
公开(公告)日：2009-09-10
申请号：US12466459
申请日：2009-05-15
申请人： Par Rosander , Lars Andersson , Bjorn Nilsson
发明人： Par Rosander , Lars Andersson , Bjorn Nilsson
IPC分类号： G09G5/00 , G06Q20/00
CPC分类号： G06F3/1423 , G06F3/147 , G06Q20/201 , G09G2380/04
摘要： An electronic label wirelessly connected to a product information updating system. The electronic label includes a wireless communication interface to receive information from a server to be displayed on a display, a means for processing connected to the communication interface, a means for updating the display connected to the means for processing, and at least one dot matrix display to display a dot matrix image, where the dot matrix display is connected to the means for updating the display. The communication interface receives the information to be displayed from the product information updating system. At least a part of the dot matrix display displays a first barcode that can be scanned by a barcode scanner, where the first barcode identifies the electronic label or a product linked to the electronic label.
摘要翻译：无线连接到产品信息更新系统的电子标签。电子标签包括：无线通信接口，用于从显示器上显示的服务器接收信息，连接到通信接口的处理装置，用于更新连接到处理装置的显示装置，以及至少一个点矩阵显示以显示点阵图像，其中点阵显示器连接到用于更新显示器的装置。通信接口从产品信息更新系统接收要显示的信息。点阵显示器的至少一部分显示可由条形码扫描仪扫描的第一条形码，其中第一条形码标识电子标签或与电子标签相关的产品。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式